
1. acta microbiol immunol hung. 2012 dec;59(4):499-510. doi:
10.1556/amicr.59.2012.4.7.

antiretroviral effect 4-thio-uridylate human immunodeficiency virus
type 1.

kanizsai s(1), ghidán a, ongrádi j, nagy k.

author information: 
(1)semmelweis university institute medical microbiology, budapest, hungary.

antiretroviral effect thiolated nucleotide 4-thio-uridylate (s4ump, designated
as ud29) human immunodeficiency virus type 1 (hiv-1) been
quantitatively determined cell-based viral infectivity assays. syntitium
inhibition assay mt-2 human t-cell line ud29 prevented cell fusion and
formation syntitia induced hiv-1iiib ic50 values 11.7 μg/ml. a
single-cycle viral infection assay (magi assay) ud29 proved potent
inhibitory effect hiv-1iiib helacd4-ltr/β-gal cells, dose
dependent ic50 values 4.75 μg/ml ic90 39.7 μg/ml. ud29 showed a
most prominent antiviral effect administered 30 min prior hiv-1 infection.
as hiv entry requires thiol/disulfide exchange process, results suggest that
reactive -sh group enol-form thiolated nucleotide may interfere with
the function cell surface proteins. ud29 cannot penetrate cells may
have interactive role redox processes active viral entry.

doi: 10.1556/amicr.59.2012.4.7 
pmid: 23195558  [indexed medline]

